Argatroban is an inhibitor of thrombin.

Argatroban is a potent and selective synthetic thrombin inhibitor with Ki ranging from 5 nM to 39 nM, used as an anticoagulant.

Dabigatran etexilate, the active prodrug of dabigatran, is a selective inhibitor of thrombin with Ki of 4.5 nM.

Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.

Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity.

Dabigatran etexilate mesylate inhibits thrombin with Ki value of 4.5 nM. It is the prodrug of dabigatran.

Enoxaparin is one of the most commonly used low-molecular-weight heparins in a wide variety of thromboembolic disorders and has several advantages over unfractionated heparin.

Amthamine dihydrobromide is a highly selective agonist of H2 receptor.

Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.

Heparin sodium, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, by activating antithrombin and causing a conformational change in ATIII and allows for increased flexibility in its reactive site loop.

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule.

AEBSF HCl is a irreversible inhibitor of proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin.